Associate Scientist - Chemistry
Id Job: 316a324
Id Job: 316a324
Redx Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted medicines for the treatment of cancer and fibrotic diseases. The Company has a strong track record of discovering new drug candidates through its core strengths in medicinal chemistry and translational science. Redx's lead oncology product candidate, the Porcupine inhibitor RXC004, being developed as a targeted treatment for Wnt-dependent cancers, is currently undertaking a Phase 2 programme as both a monotherapy and in combination with anti-PD-1. The Company's lead fibrosis product candidate, the selective ROCK2 inhibitor RXC007, is in development for interstitial lung disease and commenced a Phase 2a trial for idiopathic pulmonary fibrosis in October 2022. Redx's third drug candidate, RXC008, a GI-targeted ROCK inhibitor for the treatment of fibrostenotic Crohn's disease, is currently in pre-IND stage.
The Company's accomplishments are evidenced not only by its two wholly-owned Phase 2 clinical-stage product candidates and rapidly expanding pipeline, but also by its strategic transactions, which include significant partnering deals with both AstraZeneca and Jazz Pharmaceuticals.
The Role
Entry level laboratory-based position contributing to the discovery and delivery of novel pharmaceuticals by carrying out research to agreed objectives
Responsibilities
Requirements
Competencies
In return, we will offer you the opportunity to work at an exciting drug discovery company where you will get exposure to a broad range of activities and develop your drug discovery skills.
The closing date for applications will be 10th March 2023.
Job Type: Full-time
Salary: From £25,000.00 per year
Benefits:
Schedule:
Supplemental pay types:
Ability to commute/relocate:
Education:
Licence/Certification:
Work Location: One location